Briant Fruth - Department of Quantitative Health Sciences, Mayo Clinic

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 29 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Ronald C. Chen,Gina L. Mazza,Briant Fruth,Han Xiao,Joel Picus,Mary Ellen Taplin,Tanya B. Dorff,Leonard Joseph Appleman,Douglas Jay Weckstein,Akash Patnaik,Alan Haruo Bryce,Daniel Shevrin,James L. Mohler, Daniel M. Anderson,Arpit Rao,Alan Tan,Charles J. Ryan,Scott Eggener,Michael J. Morris,Rahul Raj Aggarwal

Journal of Clinical Oncologyno. 16_suppl (2024): 5006-5006

引用0浏览0引用

A Phase II Study of Bevacizumab and Temsirolimus in Advanced Extra-Pancreatic Neuroendocrine Tumors

Sonia M. Abuzakhm,Vineeth Sukrithan,Briant Fruth,Rui Qin,Jonathan Strosberg,Timothy J. Hobday,Thomas Semrad,Diane Reidy-Lagunes,Hedy Lee Kindler,George P. Kim,Jennifer J. Knox,Andreas Kaubisch,Miguel Villalona-Calero,Helen Chen,Charles Erlichman,Manisha H. Shah

Endocrine Related Cancer（2023）

引用1浏览0WOS引用

Abstract GS4-05: Phase II Randomized Trial of Conventional Versus Hypofractionated Post-Mastectomy Proton Radiotherapy

Robert Mutter,Sharmila Giri,Briant Fruth,Nicholas Remmes,Aman Anand,Kathryn Ruddy,Hector Villarraga, Sebastian Santos Patarroyo,Elizabeth Yan,Kenneth Merrell,Lisa Mcgee,Tamara Vern-Gross,Bradley Stish,Robert Gao,Judy C. Boughey,Sean Park,Kimberly Corbin,Carlos Vargas

Cancer researchno. 5_Supplement (2023): GS4-05

引用0浏览0引用

Patient-reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (alliance A021501)

Rebecca A. Snyder,Amylou C. Dueck,Briant Fruth,Qian Shi,Joleen M. Hubbard,Joseph M. Herman,Eileen M. O'Reilly,Matthew H. G. Katz

ANNALS OF SURGERYno. 4 (2023): 598-608

引用0浏览0WOS引用

Comparison of Quality of Life in Patients Randomized to High-Dose Once Daily (QD) Thoracic Radiotherapy (TRT) with Standard Twice Daily (BID) TRT in Limited Stage Small Cell Lung Cancer (LS-SCLC) on CALGB 30610 (alliance, Sub-study CALGB 70702)

Apar Kishor Ganti,Amylou C. Dueck,Briant Fruth,Andreas Rimner,Saiama Naheed Waqar,Michael D. Mix,William J. Petty,Jeffrey A. Bogart

Journal of clinical oncology（2022）

引用2浏览0引用

CLO22-088: Phase II Trial of Trifluridine/Tipiracil in Combination with Irinotecan in Advanced Biliary Tract Cancers (Btcs)

Sri Harsha Tella,Jaclynn Wessling,Foster Nathan,Shi Qian,Tran Nguyen, Robert McWillimas,Alberts Steven,Minetta Liu,Mitesh Borad,Wen Wee Ma,Mindy Hartgers,Leslie Washburn,Fruth Briant,Martin Fernandezzapico,Tara L Hogenson,Henry Pitot,Zhaohui Jin,Amit Mahipal

Journal of the National Comprehensive Cancer Networkno. 3.5 (2022): CLO22-088

引用1浏览0引用

A Prospective, Randomized Trial of Patient-Reported Outcome Measures to Drive Management Decisions in Hematology and Oncology

Rahma Warsame,Joselle Cook,Briant Fruth,Joleen Hubbard,Katrina Croghan,Katharine A. R. Price,Aminah Jatoi,Shaji Kumar,Carrie Thompson,Jan Buckner,Angela Dispenzieri,Jeff Sloan,Amylou C. Dueck

Contemporary Clinical Trials Communications（2022）

引用0浏览0WOS引用

How Much Time Do We Have? Longitudinal Perception of Prognosis in Newly-Diagnosed High Grade Glioma Patients and Caregivers Compared to Clinicians

Pacific Neuroscience Institute at Saint John Cancer Institute,Fruth Briant,Barrera Celina,Farfour Hannah N.,Mrugala Maciej M.,Edwin Mark K.,Sloan Jeff A.,Porter Alyx B.

Journal of neuro-oncology（2021）

引用13浏览0WOS引用

Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial

Karyn A Goodman,Fang-Shu Ou, Nathan C Hall,Tanios Bekaii-Saab,Briant Fruth,Erin Twohy, Michael O Meyers,Daniel J Boffa,Kisha Mitchell,Wendy L Frankel,Donna Niedzwiecki,Anne Noonan,Yelena Y Janjigian, Paul J Thurmes,Alan P Venook,Jeffrey A Meyerhardt,Eileen M O'Reilly,David H Ilson

Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 25 (2021): 2803-2815

引用50浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn